Details for New Drug Application (NDA): 090924
✉ Email this page to a colleague
NDA 090924 describes IBUTILIDE FUMARATE, which is a drug marketed by Avet Lifesciences, Luitpold, and Mylan Institutional, and is included in four NDAs. It is available from two suppliers. Additional details are available on the IBUTILIDE FUMARATE profile page.
The generic ingredient in IBUTILIDE FUMARATE is ibutilide fumarate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.
The generic ingredient in IBUTILIDE FUMARATE is ibutilide fumarate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.
Summary for 090924
| Tradename: | IBUTILIDE FUMARATE |
| Applicant: | Mylan Institutional |
| Ingredient: | ibutilide fumarate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.1MG/ML | ||||
| Approval Date: | Jan 11, 2010 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
